Indivior PLC at Bank of America Merrill Lynch Global Healthcare Conference Transcript
So thanks for staying with us after lunch. And as we sort of draw to the close of the presentations, it's my pleasure to be able to introduce Indivior. So some of you may be familiar with Indivior. But Mark Crossley is the CEO, and he is going to run through a presentation, just on the company opportunities in their opioid use disorder markets, and then we will open up for Q&A. So Mark, pleasure to have you here in London. The podium is all yours.
Thanks, Graham. Really appreciate it. Yes. Thanks again, Graham. And great to be here back in person. It seems like it's becoming more normal. I'll bypass the forward-looking statements, assuming everyone's read them. And let's just start with why Indivior. And I think the key here for those that don't know Indivior is we are the leaders in addiction. We're pioneering life-transforming treatments for both addiction and serious mental illness, where
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |